CIK 0001396814
- Large accelerated filer
Pacira BioSciences, Inc.
Sign in to watch- Ticker
- PCRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 510619477
- Phone
- +1 650-242-8052
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
- Former names
- Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $217,920
- in 1 filing, $218K under 10b5-1 plans
Net −$217,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-31 | GAUGLER DARYL Chief Operating Officer | Grant or award | +243.54 | $16.01 | $4K | 115,443.49 |
| 2024-12-13 | GAUGLER DARYL Chief Operating Officer | Sale 10b5-1 | −500 | $19.76 | $10K | 115,199.95 |
| 2024-09-13 | GAUGLER DARYL Chief Operating Officer | Sale 10b5-1 | −500 | $12.86 | $6K | 115,699.95 |
| 2024-06-28 | GAUGLER DARYL Chief Operating Officer | Grant or award | +160.37 | $24.32 | $4K | 116,199.95 |
| 2024-06-13 | GAUGLER DARYL Chief Operating Officer | Sale 10b5-1 | −1,000 | $28.38 | $28K | 116,039.58 |
| 2024-06-12 | GAUGLER DARYL Chief Operating Officer | Grant or award 10b5-1 | +54,300 | 117,039.58 | ||
| 2024-06-03 | GAUGLER DARYL Chief Operating Officer | Shares withheld for taxes | −2,754 | $30.89 | $85K | 62,739.58 |
| 2024-02-05 | GAUGLER DARYL Chief Operating Officer | Grant or award | +33,700 | 65,493.58 | ||
| 2023-06-14 | GAUGLER DARYL Chief Operating Officer | Grant or award | +10,000 | 31,539 | ||
| 2023-06-14 | GAUGLER DARYL Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2023-06-07 | GAUGLER DARYL Chief Operating Officer | Sale 10b5-1 | −1,047 | $37.87 | $40K | 21,539 |
| 2023-06-06 | GAUGLER DARYL Chief Operating Officer | Sale 10b5-1 | −1,005 | $38.99 | $39K | 22,586 |
| 2023-06-05 | GAUGLER DARYL Chief Operating Officer | Sale 10b5-1 | −1,000 | $38.74 | $39K | 23,591 |
| 2023-05-31 | GAUGLER DARYL Chief Operating Officer | Option exercise 10b5-1 | +2,500 | $34.00 | $85K | 26,894 |
| 2023-05-31 | GAUGLER DARYL Chief Operating Officer | Sale 10b5-1 | −2,500 | $39.08 | $98K | 24,591 |
| 2023-05-31 | GAUGLER DARYL Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,500 | 0 | ||
| 2022-06-08 | GAUGLER DARYL Chief Operating Officer | Grant or award | +7,900 | 19,394 | ||
| 2022-06-08 | GAUGLER DARYL Chief Operating Officer | Grant or award | +5,000 | 24,394 | ||
| 2022-06-08 | GAUGLER DARYL Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +19,800 | 19,800 | ||
| 2022-06-08 | GAUGLER DARYL Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 |
Page 1 of 2 · 21 trades